Chemoinformaics analysis of 1-(4-HYDROXY-3-METHOXYPHENYL)-2-BUTANONE
| Molecular Weight | 194.23 | nRot | 4 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 7 |
| Exact Molecular Weight | 194.094 | nRing | 1 |
| Solubility: LogS | -1.49 | nHRing | 0 |
| Solubility: LogP | 1.41 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 30.1111 |
| nHD | 1 | BPOL | 16.6489 |
| QED | 0.796 |
| Synth | 1.904 |
| Natural Product Likeliness | 0.68 |
| NR-PPAR-gamma | 0.877 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.296 |
| HIA | 0.009 |
| CACO-2 | -4.481 |
| MDCK | 0.0000289 |
| BBB | 0.104 |
| PPB | 0.531133 |
| VDSS | 0.932 |
| FU | 0.275377 |
| CYP1A2-inh | 0.326 |
| CYP1A2-sub | 0.873 |
| CYP2c19-inh | 0.327 |
| CYP2c19-sub | 0.794 |
| CYP2c9-inh | 0.22 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.151 |
| CYP2d6-sub | 0.883 |
| CYP3a4-inh | 0.106 |
| CYP3a4-sub | 0.417 |
| CL | 14.211 |
| T12 | 0.917 |
| hERG | 0.027 |
| Ames | 0.191 |
| ROA | 0.148 |
| SkinSen | 0.206 |
| Carcinogencity | 0.051 |
| EI | 0.739 |
| Respiratory | 0.188 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.708618 |